Catalysts · PRAX · CIK 1689548 · page 2 of 2

PRAX catalysts and FDA events, page 2.

Updated Snapshot 20261116T222116ZBuilt

The next PDUFA date, the soonest catalysts with their source quotes and the latest FDA decisions are on PRAX PDUFA dates and upcoming catalysts. This page continues the list.

Past catalysts and FDA decisions (continued)

DateDrugCompanyEventIndicationStatusSource
2H 2025Half-year disclosedvormatrigine (PRAX-628)PRAXTopline readouttreatment resistant FOSScheduledSEC 8-K Exhibit 99.1
May 2, 2025—PRAXEarnings—CompletedSEC 8-K Exhibit 99.1
May 2025Month disclosedrelutrigine (PRAX-562)PRAXTopline readout—PositiveSEC Form 10-Q
mid-2025Half-year disclosedrelutrigine (PRAX-562)PRAXTrial start—ScheduledSEC 8-K Exhibit 99.1
1H 2025Half-year disclosedelsunersen (PRAX-222)PRAXTrial start—ScheduledSEC 8-K Exhibit 99.1
2025Year disclosedrelutrigine (PRAX-562)PRAXTopline readout—ScheduledSEC Form 8-K
Q1 2025Quarter disclosed—PRAXInterim readout—ScheduledSEC 8-K Exhibit 99.1
1H 2025Half-year disclosed—PRAXTopline readout—ScheduledSEC 8-K Exhibit 99.1
Every catalyst is quoted from PRAX’s SEC filings, FDA records or ClinicalTrials.gov; each row links its primary source. Dates move; the linked filing is authoritative. Not investment advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.